• Polycystic Kidney Disease, Autosomal Recessive (PKHD1), Gene Analysis
  • Polycystic Kidney Disease, Autosomal Dominant (PKD1 and PKD2), Gene Analysis
  • Epstein-Barr Virus (EBV) Antibody Panel
  • Oncomine Dx (CDx) for Non–Small Cell Lung Cancer (NSCLC) Treatment Monitoring
  • C1 Esterase Inhibitor, Antigen
  • Electrolyte Panel, Serum
  • Adenovirus DNA, Real-time PCR, Qualitative
  • Anti-SARS-CoV-2 (Coronavirus), IgM
  • Small Lymphocytic Lymphoma, FISH
  • Warfarin Sensitivity (CYP2C9, CYP4F2, VKORC1)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Inhibitor Screen (1:1 Mix), Mixing Studiesa (aPTT mixing study panel)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Inhibitor Screen (1:1 Mix), Mixing Studiesa (aPTT mixing study panel)
Medical Test

Reference Ranges
Access to Inhibitor Screen (1:1 Mix), Mixing Studiesa (aPTT mixing study panel) is restricted.
Loading...